Cargando…

The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking

Several tumor types have been efficiently treated with PARP inhibitors (PARPis), which are now approved for the treatment of ovarian, breast, prostate, and pancreatic cancers. The BRCA1/2 genes and mutations in many additional genes involved in the HR pathway may be responsible for the HRD phenomeno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsantikidi, Aikaterini, Papadopoulou, Eirini, Metaxa-Mariatou, Vasiliki, Kapetsis, George, Tsaousis, Georgios, Meintani, Angeliki, Florou-Chatzigiannidou, Chrysiida, Gazouli, Maria, Papadimitriou, Christos, Timotheadou, Eleni, Kotsakis, Athanasios, Boutis, Anastasios, Boukovinas, Ioannis, Kampletsas, Eleftherios, Kontovinis, Loukas, Fountzilas, Elena, Andreadis, Charalampos, Karanikiotis, Charisios, Filippou, Dimitrios, Theodoropoulos, Georgios, Özdoğan, Mustafa, Nasioulas, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529941/ https://www.ncbi.nlm.nih.gov/pubmed/37761329 http://dx.doi.org/10.3390/diagnostics13182962

Ejemplares similares

Comprehensive tumor molecular profile analysis in clinical practice
por: Özdoğan, Mustafa, et al.
Publicado: (2021)

Molecular predictive markers in tumors of the gastrointestinal tract
por: Papadopoulou, Eirini, et al.
Publicado: (2016)

Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
por: Papadopoulou, Eirini, et al.
Publicado: (2019)

Tumor molecular profiling of NSCLC patients using next generation sequencing
por: Tsoulos, Nikolaos, et al.
Publicado: (2017)

RediScore: Prospective validation of a pipeline for homologous recombination deficiency analysis
por: Tsantikidi, Aikaterini, et al.
Publicado: (2023)

Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece
por: Mavroeidis, Leonidas, et al.
Publicado: (2018)

Molecular findings reveal possible resistance mechanisms in a patient with ALK-rearranged lung cancer: a case report and literature review
por: Kougioumtzi, Anastasia, et al.
Publicado: (2019)

Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy
por: Timotheadou, Eleni, et al.
Publicado: (2017)

Report of a germline double heterozygote in MSH2 and PALB2
por: Agiannitopoulos, Konstantinos, et al.
Publicado: (2020)

Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report
por: Agiannitopoulos, Konstantinos, et al.
Publicado: (2019)

Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families
por: Thodi, Georgia, et al.
Publicado: (2010)

Prognostic stratification of patients with advanced renal cell carcinoma treated with sunitinib: comparison with the Memorial Sloan-Kettering prognostic factors model
por: Bamias, Aristotelis, et al.
Publicado: (2010)

Large bilateral adrenal metastases in non-small cell lung cancer
por: Karanikiotis, Charisios, et al.
Publicado: (2004)

Clonal evolution of colorectal cancer in a patient with serially resected metastases and liquid biopsies: a case report and discussion of the literature
por: Kastrisiou, Myrto, et al.
Publicado: (2018)

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials
por: Fountzilas, George, et al.
Publicado: (2013)

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting
por: Fountzilas, George, et al.
Publicado: (2016)

Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy
por: Tsiatas, Marinos, et al.
Publicado: (2018)

Protein expression patterns of cell cycle regulators in operable breast cancer
por: Zagouri, Flora, et al.
Publicado: (2017)

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial
por: Fountzilas, George, et al.
Publicado: (2014)

A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients’ Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in Greece
por: Kokkali, Stefania, et al.
Publicado: (2022)

Chemotherapy Associated Ovarian Failure
por: Mauri, Davide, et al.
Publicado: (2020)

Application of next generation sequencing in cardiology: current and future precision medicine implications
por: Papadopoulou, Eirini, et al.
Publicado: (2023)

The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature
por: Zarkavelis, George, et al.
Publicado: (2020)

Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence
por: Christopoulou, Athina, et al.
Publicado: (2022)

Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients
por: Mihalatos, Markos, et al.
Publicado: (2005)

Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial
por: Goussia, Anna, et al.
Publicado: (2018)

Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
por: Tsoukalas, Nikolaos, et al.
Publicado: (2020)

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
por: Kontovinis, Loukas F, et al.
Publicado: (2009)

Is There an Independent Role of TERT and NF1 in High Grade Gliomas?
por: Razis, Evangelia, et al.
Publicado: (2019)

1707P CureCancer digital tool in the routine clinical oncology practice facilitates PROs, communicating with HCPs, treatment adherence and “distancing interventions” during COVID-19 and reduces costs: A feasibility and satisfaction study
por: Galiti, D., et al.
Publicado: (2020)

Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma
por: Papazisis, Konstantinos T, et al.
Publicado: (2010)

Cosmology: the structure and evolution of the universe
por: Contopoulos, Georgios, et al.
Publicado: (1987)

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group
por: Fountzilas, Elena, et al.
Publicado: (2020)

Delayed malignant melanoma recurrence simulating primary ovarian cancer: Case report
por: Boutis, Anastasios, et al.
Publicado: (2008)

Interior Design: A New Perspective in Supportive Care of Patients with Acute Onset of Debilitating Diseases
por: Mauri, Davide, et al.
Publicado: (2021)

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study
por: Papadimitriou, Christos A, et al.
Publicado: (2011)

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
por: PAPADOPOULOU, EIRINI, et al.
Publicado: (2015)

Exosomal noncoding RNAs in cholangiocarcinoma: Laboratory noise or hope?
por: Laschos, Konstantinos, et al.
Publicado: (2020)

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer
por: Stathopoulos, G P, et al.
Publicado: (2006)

Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group
por: Mavroudis, Dimitrios, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h8sbduhvvrdtlui2epa88ea4m3